Intercept Pharmaceuticals, Inc. (ICPT) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Product
011M22M34M45M56M68M79M90MQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
050M100M150M200M250M300M350M400MQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Margin (%)

Gross MarginOperating MarginNet Income Margin
050100150200250300350400Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Operating Expenses

Research And Development ExpensesSelling General And Administrative Expenses
025M50M75M100M125M150M175M200MQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

EBITDA

EBITDA
-40M-34M-28M-23M-17M-11M-6M250K6MQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

EPS

EPSEPS Diluted
02581012151820Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Revenue Variation (%)

Revenue Variation
-20-14-8-1511182430Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
0255075100125150175200Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Revenue YoY Variation (%)

Revenue YoY Variation
-30-24-18-11-5181420Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
050100150200250300350400Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Price-to-Earning Ratio

P/E Ratio
-80-70-60-50-40-29-19-91Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
038M75M112M150M188M225M262M300MQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
012346789Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023
💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
05M10M15M20M25M30M35M40MQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Free Cash Flow

Cash At End Of Period
025M50M75M100M125M150M175M200MQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
02M5M8M10M12M15M18M20MQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023
🏦 Balance Sheet
📈 Key Metrics